 |
|
|
| |
Activity & Genotypic and Phenotypic Analysis of HCV NS5B Variants Selected from Patients Treated with VCH-916
|
| |
| |
44th EASL April 23-26 2009 Copenhagen
Reported by Jules Levin
O. Nicolas, I. Boivin, A. Berneche D'Amours, P. Fex, F. Denis, S. Selliah, and J. Bedard
ViroChem Pharma Incorporated, Laval, QC, Canada
Supported by ViroChem Pharma Incorporated, a wholly-owned subsidiary of Vertex Pharmaceuticals Incorporated
|
| |
|
|
|
|
|
